跳至主要内容
临床试验/EUCTR2012-004546-15-FR
EUCTR2012-004546-15-FR进行中(未招募)1 期

Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up - Unwanted events in naive pediatric population treated by antipsychotic

CHU de Nice0 个研究点目标入组 340 人开始时间: 2013年6月19日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CHU de Nice
入组人数
340

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male or female patients
  • 6 •In whom antipsychotic treatment is indicated
  • Who have never been treated with antipsychotic medication (other than metoclopramide (Primperan®) for pediatric indications).
  • - Receiving an antipsychotic for less than 15 days
  • - Without history of exhibition in an antipsychotic or with a history of grip of antipsychotic of less than three consecutive months interrupted for more than six months before the inclusion
  • - Hospitalized ( e ) in full-time or day department, or seen ambulatory
  • - Obtaining of the lit consent, the patient and his parents or the legal person in charge
  • - Obtaining of the consent lit by the patient become major during the follow-up
  • - Membership in a national insurance scheme
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 340
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
CHU de Nice

相似试验